APCCC 2019 Conference Coverage - Results from #20

Viewing 21-40 of 58 articles

APCCC 2019: Local Treatment of the Primary (RT) in the Metastatic Situation

APCCC 2019: Imaging Bone (flare) Responses in Advanced Prostate Cancer

APCCC 2019: First-line mCRPC after Docetaxel or AR Pathway Inhibitor in the mHSPC Setting

APCCC 2019: The Best Use of Osteoclast-Targeted Therapy in CRPC

APCCC 2019: Prevention and Treatment of Osteoporosis: What More do We Need to Know?

APCCC 2019: Debate: Antiresorptive Therapy to Reduce SRE Risk in Men with Bone mCRPC -- For the Majority of Men with CRPC and Bone Metastases

APCCC 2019: Follow-up on ADT Alone vs ADT "Plus"

APCCC 2019: Debate: Treatment of Non-Metastatic Castration-Resistant Prostate Cancer – Pros

APCCC 2019: Debate: Treatment of Non-Metastatic Castration-Resistant Prostate Cancer – Cons

APCCC19: Outcomes Research – IRONMAN Project – Preliminary Results Update

APCCC 2019: Neuroendocrine Prostate Cancer Spectrum - Diagnosis and Treatment

APCCC 2019: Subgroup Analysis of mCRPC Trials

APCCC 19: Wishes From a Patient's Perspective

APCCC 2019: Definition and Overview of Treatment Options in nmCRPC

APCCC 2019: An Update on the IRONMAN Project

APCCC 2019: The Aging Population: Onco-geriatric Assessment and Treatment Considerations

APCCC 2019: Report and Lessons Learned from the Consensus Conference for Developing Countries

APCCC 2019: Disparities in Prostate Cancer Management in the United States

APCCC 2019: De Novo Oligometastatic Prostate Cancer: Consensus and Controversy on Aims, Options and Rationale

APCCC 2019: Ethnicity and Prognosis of Prostate Cancer

1
2
3